Historical salary details - Dr. David S. Grayzel, M.D., Independent Director, Q32 Bio Inc.
Dr. David S. Grayzel, M.D. is the Independent Director of Q32 Bio Inc.. They also hold 1 other positions in and Jade Biosciences Inc.
Dr. David S. Grayzel, M.D.
Independent Director
$ 199.1 K
Gross Remuneration
-
Current Company
Q32 Bio Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Q32 Bio Inc. | Independent Director | 199.1 K | - |
| 2024 | Jade Biosciences Inc | Independent Director | - | - |
| 2023 | Jade Biosciences Inc | Independent Director | 226.0 K | 48.5 % |
| 2022 | Jade Biosciences Inc | Independent Director | 152.2 K | -35.9 % |
| 2021 | Jade Biosciences Inc | Independent Director | 237.5 K | - |
| 2020 | Jade Biosciences Inc | Independent Director | - | - |
| 2020 | Xilio Therapeutics Inc | Independent Director | - | - |